Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Jan;105(1):129–134. doi: 10.1111/j.1476-5381.1992.tb14223.x

One way cross tolerance between cromakalim and salbutamol in the uterus of the rat in vivo.

S J Downing 1, M Hollingsworth 1
PMCID: PMC1908624  PMID: 1317733

Abstract

1. Cross tolerance between the potassium (K+) channel opener, cromakalim and the beta 2-adrenoceptor agonist, salbutamol, was investigated in the uterus of the non-pregnant rat in vivo. Uterine sensitivity to salbutamol was similar in both vehicle-treated and cromakalim-tolerant rats. In salbutamol-tolerant rats, uterine responses to cromakalim were markedly decreased compared with saline-infused rats, such that maximum inhibition of uterine contractions was less than 40%. 2. Propranolol treatment and salbutamol tolerance each produced similar reductions in sensitivity of the uterus to salbutamol of approximately 10 fold. The same dose of propranolol did not influence uterine sensitivity to cromakalim, which suggests that the relaxant action of cromakalim is not due to a direct or indirect activation of uterine beta 2-adrenoceptors. 3. Salbutamol produced a marked (11.7 fold) increase in uterine adenosine 3':5'-cyclic monophosphate (cyclic AMP) concentrations measured ex vivo, which was completely inhibited by propranolol pretreatment, but was unaffected by glibenclamide pretreatment. Cromakalim did not increase uterine cyclic AMP concentrations, suggesting that stimulation of adenylate cyclase is not significant in the uterine relaxant action of cromakalim. 4. The lack of propranolol antagonism of cromakalim and of cromakalim-induced changes in uterine cyclic AMP concentrations suggests that the cross tolerance observed between salbutamol and cromakalim may be at the level of K(+)-channels.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel M. H., Hollingsworth M. The effects of long-term infusion of salbutamol, diltiazem and nifedipine on uterine contractions in the ovariectomized, post-partum rat. Br J Pharmacol. 1986 Jul;88(3):577–584. doi: 10.1111/j.1476-5381.1986.tb10238.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buckingham R. E., Hamilton T. C., Howlett D. R., Mootoo S., Wilson C. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol. 1989 May;97(1):57–64. doi: 10.1111/j.1476-5381.1989.tb11923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cavero I., Mondot S., Mestre M. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther. 1989 Mar;248(3):1261–1268. [PubMed] [Google Scholar]
  4. Cook N. S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci. 1988 Jan;9(1):21–28. doi: 10.1016/0165-6147(88)90238-6. [DOI] [PubMed] [Google Scholar]
  5. Diamond J., Marshall J. M. A comparison of the effects of various smooth muscle relaxants on the electrical and mechanical activity of rat uterus. J Pharmacol Exp Ther. 1969 Jul;168(1):21–30. [PubMed] [Google Scholar]
  6. Downing S. J., Miller M., Hollingsworth M. Tolerance to cromakalim in the rat uterus in vivo. Br J Pharmacol. 1989 Mar;96(3):732–738. doi: 10.1111/j.1476-5381.1989.tb11875.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Downing S. J., Sherwood O. D. The physiological role of relaxin in the pregnant rat. II. The influence of relaxin on uterine contractile activity. Endocrinology. 1985 Mar;116(3):1206–1214. doi: 10.1210/endo-116-3-1206. [DOI] [PubMed] [Google Scholar]
  8. Eltze M. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery. Eur J Pharmacol. 1989 Jun 20;165(2-3):231–239. doi: 10.1016/0014-2999(89)90717-6. [DOI] [PubMed] [Google Scholar]
  9. Ewald D. A., Williams A., Levitan I. B. Modulation of single Ca2+-dependent K+-channel activity by protein phosphorylation. Nature. 1985 Jun 6;315(6019):503–506. doi: 10.1038/315503a0. [DOI] [PubMed] [Google Scholar]
  10. Gelband C. H., Lodge N. J., Van Breemen C. A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalim. Eur J Pharmacol. 1989 Aug 22;167(2):201–210. doi: 10.1016/0014-2999(89)90580-3. [DOI] [PubMed] [Google Scholar]
  11. Groschner K., Silberberg S. D., Gelband C. H., van Breemen C. Ca2(+)-activated K+ channels in airway smooth muscle are inhibited by cytoplasmic adenosine triphosphate. Pflugers Arch. 1991 Jan;417(5):517–522. doi: 10.1007/BF00370948. [DOI] [PubMed] [Google Scholar]
  12. Hamilton T. C., Weston A. H. Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol. 1989;20(1):1–9. doi: 10.1016/0306-3623(89)90052-9. [DOI] [PubMed] [Google Scholar]
  13. Harden T. K. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev. 1983 Mar;35(1):5–32. [PubMed] [Google Scholar]
  14. Izumi H., Kishikawa T. Effects of ritodrine, a beta 2-adrenoceptor agonist, on smooth muscle cells of the myometrium of pregnant rats. Br J Pharmacol. 1982 Jul;76(3):463–471. doi: 10.1111/j.1476-5381.1982.tb09241.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Johansson S. R., Andersson R. G. Effects of beta-adrenergic agonists on rat uterine motility and cAMP level in vivo. Acta Pharmacol Toxicol (Copenh) 1980 Jul;47(1):5–10. doi: 10.1111/j.1600-0773.1980.tb01651.x. [DOI] [PubMed] [Google Scholar]
  16. Johansson S. R., Andersson R. G. Mechanisms of beta-adrenergic desensitization in rat myometrium. Acta Pharmacol Toxicol (Copenh) 1981 Oct;49(4):241–247. doi: 10.1111/j.1600-0773.1981.tb00901.x. [DOI] [PubMed] [Google Scholar]
  17. Kroeger E. A., Marshall J. M. Beta-adrenergic effects on rat myometrium: mechanisms of membrane hyperpolarization. Am J Physiol. 1973 Dec;225(6):1339–1345. doi: 10.1152/ajplegacy.1973.225.6.1339. [DOI] [PubMed] [Google Scholar]
  18. Kume H., Takai A., Tokuno H., Tomita T. Regulation of Ca2+-dependent K+-channel activity in tracheal myocytes by phosphorylation. Nature. 1989 Sep 14;341(6238):152–154. doi: 10.1038/341152a0. [DOI] [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. Newgreen D. T., Bray K. M., McHarg A. D., Weston A. H., Duty S., Brown B. S., Kay P. B., Edwards G., Longmore J., Southerton J. S. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br J Pharmacol. 1990 Jul;100(3):605–613. doi: 10.1111/j.1476-5381.1990.tb15854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Piper I., Minshall E., Downing S. J., Hollingsworth M., Sadraei H. Effects of several potassium channel openers and glibenclamide on the uterus of the rat. Br J Pharmacol. 1990 Dec;101(4):901–907. doi: 10.1111/j.1476-5381.1990.tb14178.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Post J. M., Smith J. M., Jones A. W. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium. J Pharmacol Exp Ther. 1989 Aug;250(2):591–597. [PubMed] [Google Scholar]
  23. Riemer R. K., Wu Y. Y., Bottari S. P., Jacobs M. M., Goldfien A., Roberts J. M. Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium. Mol Pharmacol. 1988 Apr;33(4):389–395. [PubMed] [Google Scholar]
  24. Sadoshima J., Akaike N., Kanaide H., Nakamura M. Cyclic AMP modulates Ca-activated K channel in cultured smooth muscle cells of rat aortas. Am J Physiol. 1988 Oct;255(4 Pt 2):H754–H759. doi: 10.1152/ajpheart.1988.255.4.H754. [DOI] [PubMed] [Google Scholar]
  25. Williams D. L., Jr, Katz G. M., Roy-Contancin L., Reuben J. P. Guanosine 5'-monophosphate modulates gating of high-conductance Ca2+-activated K+ channels in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9360–9364. doi: 10.1073/pnas.85.23.9360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wilson C. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro. J Auton Pharmacol. 1989 Feb;9(1):71–78. doi: 10.1111/j.1474-8673.1989.tb00198.x. [DOI] [PubMed] [Google Scholar]
  27. Winquist R. J., Heaney L. A., Wallace A. A., Baskin E. P., Stein R. B., Garcia M. L., Kaczorowski G. J. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther. 1989 Jan;248(1):149–156. [PubMed] [Google Scholar]
  28. Yamaguchi H., Honeyman T. W., Fay F. S. Beta-adrenergic actions on membrane electrical properties of dissociated smooth muscle cells. Am J Physiol. 1988 Mar;254(3 Pt 1):C423–C431. doi: 10.1152/ajpcell.1988.254.3.C423. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES